Genell L. Knatterud - Concepedia

Author

Genell L. Knatterud

Also Known As

G Knatterud, G L Knatterud, G. KNATTERUD, G. Knatterud, G. L. Knatterud, G.L. Knatterud, GENELL L. KNATTERUD, GENELL L. KNATTERUD, Genell Knatterud, Genell Knatterud (deceased)

151

Publications

20.1K

Citations

H-Index

139

Concepts

All Affiliations

Maryland Medical Research Institute National Heart Lung and Blood Institute Brigham and Women's Hospital Cleveland Clinic Montreal Heart Institute

About

Genell L. Knatterud is an author at Maryland Medical Research Institute specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	62	10.4K
2	Health Sciences	8	13	1.1K
3	Engineering	4	4	195
4	Education	1	1	420
5	Management	1	1	10

Genell L. Knatterud

Publications

18.1K

Citations

H-Index

Page 1

	Year	Citations
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. James H. Chesebro, Genell L. Knatterud, Robert Roberts, Circulation ThrombosisHospital DischargeCardiovascular DiseaseIntravenous StreptokinaseAtherosclerosis	1987	2.2K
Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis Robert P. Baughman, Alvin S. Teirstein, Marc A. Judson, American Journal of Respiratory and Critical Care Medicine	2001	1.8K
Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin Elizabeth Ziegler, Charles J. Fisher, Charles L. Sprung, New England Journal of Medicine	1991	1.6K
Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase Anupama Rao, Craig M. Pratt, Andrew Berke, Journal of the American College of Cardiology ThrombosisPlasma FibrinogenCardiovascular DiseaseFibrinolytic SystemHematology	1988	986
A Case Control Etiologic Study of Sarcoidosis Lee S. Newman, Cecile S. Rose, Eddy A. Bresnitz, American Journal of Respiratory and Critical Care Medicine Occupational Health SciencesPathologyOccupational ExposuresSocial Determinants Of HealthOccupational Exposure	2004	792
Coronary Intervention for Persistent Occlusion after Myocardial Infarction Judith S. Hochman, Gervasio A. Lamas, Christopher E. Buller, New England Journal of Medicine	2006	735
Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* J. H. Chesebro, Genell L. Knatterud, Robert Roberts, ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseAtherosclerosisAcutemyocardial Infarction	1987	735
Photocoagulation Treatment of Proliferative Diabetic Retinopathy: The Second Report of Diabetic Retinopathy Study Findings Arnall Patz, Stuart L. Fine, Daniel Finkelstein, Ophthalmology Second ReportDiabetic RetinopathyOcular DiseaseProliferative Diabetic RetinopathyOphthalmology	1978	653
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Matthew D. Davis, M Fisher, Ronald E. Gangnon, PubMed	1998	460
Asymptomatic Cardiac Ischemia Pilot (ACIP) Study Two-Year Follow-up Richard F. Davies, A.David Goldberg, Sandra Forman, Circulation	1997	453

Page 1